Cargando…

The Strategy of Conditionally Replicating Adenovirus-Mediated PreS2 Mini-Antibody Expression Has Dual Effects of Inhibiting HBV Infection and Preventing Hepatocellular Carcinoma

AIM: To investigate the inhibitory effect of hepatitis B virus (HBV) preS2 mini-antibody (mPreS2) against HBV infection, HBV-associated liver injury and HBV-associated hepatic carcinogenesis. METHODS: A recombinant adenovirus vector with the human survivin promoter and mPreS2 gene, Ad5SVP-mPreS2, wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Ziheng, Zeng, Su, Xu, Peipei, Liu, Wenfei, Wang, Shoufei, Xia, Xiaotian, Su, Changqing, Guo, Minggao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917352/ https://www.ncbi.nlm.nih.gov/pubmed/33658851 http://dx.doi.org/10.2147/CMAR.S298331

Ejemplares similares

Prediction of lung metastases in thyroid cancer using machine learning based on SEER database
por: Liu, Wenfei, et al.
Publicado: (2022)

The Prognostic Implication of the BRAF V600E Mutation in Papillary Thyroid Cancer in a Chinese Population
por: Ye, Ziheng, et al.
Publicado: (2022)

Development of a joint diagnostic model of thyroid papillary carcinoma with artificial neural network and random forest
por: Wang, Shoufei, et al.
Publicado: (2022)

A Proposed Heterogeneous Ensemble Algorithm Model for Predicting Central Lymph Node Metastasis in Papillary Thyroid Cancer
por: Liu, Wenfei, et al.
Publicado: (2022)

Mutations in the HBV PreS/S gene related to hepatocellular carcinoma in Vietnamese chronic HBV-infected patients
por: Thi Cam Huong, Nguyen, et al.
Publicado: (2022)

Sparse logistic regression revealed the associations between HBV PreS quasispecies and hepatocellular carcinoma
por: Jia, Jian-an, et al.
Publicado: (2022)

Whole genome HBV deletion profiles and the accumulation of preS deletion mutant during antiviral treatment
por: Zhang, Dake, et al.
Publicado: (2012)

Risk Factor Analysis for Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma
por: Liu, Wenfei, et al.
Publicado: (2021)

HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma
por: Liu, Peng, et al.
Publicado: (2015)

Use of MicroRNA Let-7 to Control the Replication Specificity of Oncolytic Adenovirus in Hepatocellular Carcinoma Cells
por: Jin, Huajun, et al.
Publicado: (2011)

HBV preS Mutations Promote Hepatocarcinogenesis by Inducing Endoplasmic Reticulum Stress and Upregulating Inflammatory Signaling
por: Liu, Wenbin, et al.
Publicado: (2022)

Association of preS/S Mutations with Occult Hepatitis B Virus (HBV) Infection in South Korea: Transmission Potential of Distinct Occult HBV Variants
por: Kim, Hong, et al.
Publicado: (2015)

Antibiotic-induced gut bacteria depletion has no effect on HBV replication in HBV immune tolerance mouse model
por: Bu, Yanan, et al.
Publicado: (2023)

Diverse Effects of the NTCP p.Ser267Phe Variant on Disease Progression During Chronic HBV Infection and on HBV preS1 Variability
por: Yang, Fangji, et al.
Publicado: (2019)

HBV preS deletion mapping using deep sequencing demonstrates a unique association with viral markers
por: Suzuki, Yuichiro, et al.
Publicado: (2019)

The dual functions of KDM7A in HBV replication and immune microenvironment
por: Yang, Di, et al.
Publicado: (2023)

LpCat1 Promotes Malignant Transformation of Hepatocellular Carcinoma Cells by Directly Suppressing STAT1
por: Ji, Weidan, et al.
Publicado: (2021)

Parathyroid cysts: experience of a rare phenomenon at a single institution
por: Xu, Peipei, et al.
Publicado: (2018)

Nucleotide variants in hepatitis B virus preS region predict the recurrence of hepatocellular carcinoma
por: Chen, Xi, et al.
Publicado: (2021)

Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection
por: Chen, Jian-Lin, et al.
Publicado: (2016)

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity
por: Yuan, Si-Yu, et al.
Publicado: (2022)

No more helper adenovirus: production of gutless adenovirus (GLAd) free of adenovirus and replication-competent adenovirus (RCA) contaminants
por: Lee, Dongwoo, et al.
Publicado: (2019)

An HBV-encoded miRNA activates innate immunity to restrict HBV replication
por: Zhao, Xiaoqing, et al.
Publicado: (2019)

Simultaneously inhibition of HIV and HBV replication through a dual small interfering RNA expression system
por: Wu, Kailang, et al.
Publicado: (2007)

PreS/2-21-Guided siRNA Nanoparticles Target to Inhibit Hepatitis B Virus Infection and Replication
por: Gao, Lixia, et al.
Publicado: (2022)

Antiviral Effects of Curcumin on Adenovirus Replication
por: Jennings, Morgan R., et al.
Publicado: (2020)

Silencing of TCTN1 inhibits proliferation, induces cell cycle arrest and apoptosis in human thyroid cancer
por: Xu, Peipei, et al.
Publicado: (2017)

HBX-Mediated Migration of HBV-Replicating HepG2 Cells: Insights on Development of Hepatocellular Carcinoma
por: Feng, Huixing, et al.
Publicado: (2009)

Enchanced levels of apolipoprotein M during HBV infection feedback suppresses HBV replication
por: Gu, Jin-Gang, et al.
Publicado: (2011)

HBV replication is significantly reduced by IL-6
por: Kuo, Tzer-Min, et al.
Publicado: (2009)

Advances in HBV infection and replication systems in vitro
por: Xu, Ruirui, et al.
Publicado: (2021)

Recurrent HBV Integration Targets as Potential Drivers in Hepatocellular Carcinoma
por: Lin, Selena Y., et al.
Publicado: (2021)

NKG2C(+) natural killer cell function improves the control of HBV replication in individuals with acute HIV infection coinfected with HBV
por: Song, Ting, et al.
Publicado: (2020)

PReS-FINAL-1010: circulating micrornas in traps
por: Lucherini, OM, et al.
Publicado: (2013)

PReS13-SPK-1469: Juvenile scleroderma
por: Zulian, F
Publicado: (2013)

PReS13-SPK-1588: Recurrent fevers
por: Frenkel, J
Publicado: (2013)

PReS-FINAL-2220: Cochlear involvement in FMF
por: Keskindemirci, G, et al.
Publicado: (2013)

PReS13-SPK-1033: Neonatal lupus
por: Cimaz, R
Publicado: (2013)

PReS-FINAL-2221: An earliest diagnosis of FMF
por: Keskindemirci, G, et al.
Publicado: (2013)

PReS13-SPK-1030: Juvenile dermatomyositis
por: Quartier, P
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3bi4a7oi97ig865bqmft1jg2a5